Seattle, WACIK 16942974 filings on record
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeLargest positions by weight
20 positions · Q4 2025
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Anebulo Pharmaceuticals Inc | 15.47M | $84.76M | 35.7% | 0 | Held |
| 2 | Foster L B Co | 1.19M | $32.10M | 13.5% | −122.1K | Reduced |
| 3 | Lifecore Biomedical Inc | 1.3K | $23.03M | 9.7% | 0 | Held |
| 4 | Nektar Therapeutics |
| 331.1K |
| $14.00M |
| 5.9% |
| 0 |
| Held |
| 5 | Regenxbio Inc | 923.7K | $13.30M | 5.6% | 0 | Held |
| 6 | Mineralys Therapeutics Inc | 358.3K | $13.00M | 5.5% | 0 | Held |
| 7 | Stoneridge Inc | 2.19M | $12.70M | 5.3% | +87.2K | Added |
| 8 | Mayville Engr Co Inc | 414.3K | $7.76M | 3.3% | +14.4K | Added |
| 9 | Culp Inc | 1.86M | $6.62M | 2.8% | 0 | Held |
| 10 | Phenixfin Corp | 117.9K | $5.21M | 2.2% | 0 | Held |
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio